article Open AccessTop 1% cited
Organometallic ruthenium-based antitumor compounds with novel modes of action
Journal of Organometallic Chemistry · 2010 · Vol. 696(5) · pp. 989–998
Wee Han Ang(National University of Singapore)Angela Casini(École Polytechnique Fédérale de Lausanne)Gianni Sava(University of Trieste)Paul J. Dyson✉(École Polytechnique Fédérale de Lausanne)
Metal complexes synthesis and propertiesFerrocene Chemistry and ApplicationsClick Chemistry and ApplicationsChemistryRutheniumRational designCombinatorial chemistryAnticancer drugMoleculeGroup 2 organometallic chemistryDrug designDrugStereochemistry
Citations
361
FWCI
13.48
field-weighted impact
References
92
Percentile
99%
vs. same field & year
Citations per year
Cited by
Advances in the design of organometallic anticancer complexes
Journal of Organometallic Chemistry · 2017 · 364 citations
Rhodium(III) and iridium(III) complexes as anticancer agents
Inorganica Chimica Acta · 2012 · 194 citations
Combination of Ru(<scp>ii</scp>) complexes and light: new frontiers in cancer therapy
Chemical Science · 2015 · 548 citations
A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds
Dalton Transactions · 2013 · 438 citations
References
Areneruthenium complexes as anticancer agents
Dalton Transactions · 2009 · 632 citations
Hyperthermia adds to chemotherapy
European Journal of Cancer · 2008 · 537 citations
Cellular processing of platinum anticancer drugs
Nature Reviews Drug Discovery · 2005 · 3,720 citations
The role of glutathione-S-transferase in anti-cancer drug resistance
Oncogene · 2003 · 1,337 citations
In Vitro and in Vivo Evaluation of Ruthenium(II)−Arene PTA Complexes
Journal of Medicinal Chemistry · 2005 · 769 citations
The resurgence of platinum-based cancer chemotherapy
Nature reviews. Cancer · 2007 · 4,639 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.